Suzhou Basecare Medical (HKSE:02170) Days Sales Outstanding : 237.27 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical Days Sales Outstanding?

Suzhou Basecare Medical's average Accounts Receivable for the six months ended in Dec. 2023 was HK$174.1 Mil. Suzhou Basecare Medical's Revenue for the six months ended in Dec. 2023 was HK$133.9 Mil. Hence, Suzhou Basecare Medical's Days Sales Outstanding for the six months ended in Dec. 2023 was 237.27.

The historical rank and industry rank for Suzhou Basecare Medical's Days Sales Outstanding or its related term are showing as below:

HKSE:02170' s Days Sales Outstanding Range Over the Past 10 Years
Min: 211.65 Med: 261.86 Max: 329.87
Current: 265.09

During the past 6 years, Suzhou Basecare Medical's highest Days Sales Outstanding was 329.87. The lowest was 211.65. And the median was 261.86.

HKSE:02170's Days Sales Outstanding is ranked worse than
95.17% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.88 vs HKSE:02170: 265.09

Suzhou Basecare Medical's Days Sales Outstanding declined from Dec. 2022 (334.29) to Dec. 2023 (237.27).

Suzhou Basecare Medical Days Sales Outstanding Historical Data

The historical data trend for Suzhou Basecare Medical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical Days Sales Outstanding Chart

Suzhou Basecare Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

211.65

255.27

315.08

329.87

252.58

Suzhou Basecare Medical Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial					332.36	324.05	334.29	320.11	237.27

Competitive Comparison of Suzhou Basecare Medical's Days Sales Outstanding

For the Medical Devices subindustry, Suzhou Basecare Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Basecare Medical's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's Days Sales Outstanding falls into.

Suzhou Basecare Medical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Suzhou Basecare Medical's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (147.442	+	167.393)	/	2 )	/	227.48	*	365
=	157.4175					/	227.48	*	365
=	252.58

Suzhou Basecare Medical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (180.803	+	167.393)	/	2 )	/	133.911	*	365 / 2
=	174.098					/	133.911	*	365 / 2
=	237.27

Suzhou Basecare Medical (HKSE:02170) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Suzhou Basecare Medical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Basecare Medical (HKSE:02170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000

Website

https://www.basecare.cn

Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.

Executives

Orbimed Capital Llc	2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited	2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited	2101 Beneficial owner
Dawn Capital Fund	2101 Beneficial owner
Dawn Capital Limited	2102 Investment manager
Hh Spr-xiv Cy Holdings Limited	2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited	2101 Beneficial owner
Hh Spr-xiv Holdings L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager

Suzhou Basecare Medical (HKSE:02170) Headlines

No Headlines